The estimated Net Worth of Michael P. Manzo is at least $6.84 Million dollars as of 11 July 2019. Mr. Manzo owns over 19,750 units of AB Active ETFs Inc stock worth over $6,463,956 and over the last 10 years he sold EYEG stock worth over $4,740. In addition, he makes $367,852 as Vice President - Engineering at AB Active ETFs Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Manzo EYEG stock SEC Form 4 insiders trading
Michael has made over 2 trades of the AB Active ETFs Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 19,750 units of EYEG stock worth $4,740 on 11 July 2019.
The largest trade he's ever made was selling 19,750 units of AB Active ETFs Inc stock on 11 July 2019 worth over $4,740. On average, Michael trades about 676 units every 20 days since 2015. As of 11 July 2019 he still owns at least 174,796 units of AB Active ETFs Inc stock.
You can see the complete history of Mr. Manzo stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Manzo biography
Michael Manzo serves as Vice President - Engineering of the Company. He has been with us since October 2006 and has served as Vice President of Engineering for the last seven years. Mr. Manzo has over 30 years of experience in product development and manufacturing in the medical device industry. Prior to working at EyeGate, Mr. Manzo held positions of President and Chief Operating Officer (2002 – 2006) at Jenline Industries, Ltd., which is now part of Helix Medical, LLC. He has been part of multiple start-up companies over the years, ranging in medical specialties from cardiology, radiology, urology and laparoscopic surgery. Mr. Manzo holds a Masters in Business Administration Degree from Suffolk University and a Bachelor of Science Degree in engineering from University of Massachusetts, Lowell.
What is the salary of Michael Manzo?
As the Vice President - Engineering of AB Active ETFs Inc, the total compensation of Michael Manzo at AB Active ETFs Inc is $367,852. There are 1 executives at AB Active ETFs Inc getting paid more, with Stephen From having the highest compensation of $601,340.
How old is Michael Manzo?
Michael Manzo is 60, he's been the Vice President - Engineering of AB Active ETFs Inc since 2006. There are 3 older and 5 younger executives at AB Active ETFs Inc. The oldest executive at AB Active ETFs Inc is Morton Goldberg, 82, who is the Independent Director.
What's Michael Manzo's mailing address?
Michael's mailing address filed with the SEC is C/O EYEGATE PHARMACEUTICALS, INC., 271 WAVERLEY OAKS ROAD, SUITE 108, WALTHAM, MA, 02452.
Insiders trading at AB Active ETFs Inc
Over the last 10 years, insiders at AB Active ETFs Inc have traded over $15,523,641 worth of AB Active ETFs Inc stock and bought 17,254,349 units worth $18,625,708 . The most active insiders traders include Capital, Llc Armistice Capi..., Peter Greenleaf, and (Innoven Partenaires S.A.) .... On average, AB Active ETFs Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,985,138. The most recent stock trade was executed by Capital, Llc Armistice Capi... on 30 July 2021, trading 260,963 units of EYEG stock currently worth $647,188.
What does AB Active ETFs Inc's logo look like?
Complete history of Mr. Manzo stock trades at AB Active ETFs Inc
AB Active ETFs Inc executives and stock owners
AB Active ETFs Inc executives and other stock owners filed with the SEC include:
-
Stephen From,
President, Chief Executive Officer, Director -
Michael Manzo,
Vice President - Engineering -
Sarah Romano,
Chief Financial Officer -
Paul Chaney,
Independent Chairman of the Board -
Praveen Tyle,
Independent Director -
Thomas Hancock,
Independent Director -
Bernard Malfroy-Camine,
Independent Director -
Morton Goldberg,
Independent Director -
Keith Maher,
Director -
Steven Boyd,
Director -
Brenda Mann,
VP of Research & Development -
Michael Garanzini,
Chief Commercial Officer -
Peter Greenleaf,
Director -
Barbara Wirostko,
Chief Medical Officer -
(Innoven Partenaires S.A.) ...,
10% owner -
Private Equity Natixis,
10% owner -
Thomas Balland,
Director -
Ventech B Fcpr,
10% owner -
Capital Ii Ventech,
10% owner -
Mounia Chaoui,
Director -
Ryan Randall Brenneman,
Chief Financial Officer -
Franz Obermayr,
Acting CEO -
Kenneth L Gayron,
Director -
Aron Shapiro,
Director -
Brian M. Strem,
President and CEO